240 related articles for article (PubMed ID: 22607890)
1. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
Shi D; Vine DF
Fertil Steril; 2012 Jul; 98(1):185-93. PubMed ID: 22607890
[TBL] [Abstract][Full Text] [Related]
2. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
[TBL] [Abstract][Full Text] [Related]
3. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
Jovanovic VP; Carmina E; Lobo RA
Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
[TBL] [Abstract][Full Text] [Related]
4. Rodent models for human polycystic ovary syndrome.
Walters KA; Allan CM; Handelsman DJ
Biol Reprod; 2012 May; 86(5):149, 1-12. PubMed ID: 22337333
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
Lambrinoudaki I
Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
[TBL] [Abstract][Full Text] [Related]
6. Metformin in polycystic ovary syndrome.
Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome--searching for an animal model.
Szukiewicz D; Uilenbroek JT
J Med; 1998; 29(5-6):259-75. PubMed ID: 10503163
[TBL] [Abstract][Full Text] [Related]
8. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.
Wiltgen D; Spritzer PM
Fertil Steril; 2010 Nov; 94(6):2493-6. PubMed ID: 20338557
[TBL] [Abstract][Full Text] [Related]
9. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.
Amato MC; Verghi M; Galluzzo A; Giordano C
Hum Reprod; 2011 Jun; 26(6):1486-94. PubMed ID: 21447694
[TBL] [Abstract][Full Text] [Related]
10. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
Chang AY; Wild RA
Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
12. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
13. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
van Houten EL; Visser JA
Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
[TBL] [Abstract][Full Text] [Related]
14. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
[TBL] [Abstract][Full Text] [Related]
15. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
Fertil Steril; 2009 Aug; 92(2):626-34. PubMed ID: 18706545
[TBL] [Abstract][Full Text] [Related]
16. Androgens and polycystic ovary syndrome.
Nisenblat V; Norman RJ
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
[TBL] [Abstract][Full Text] [Related]
17. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?
Daskalopoulos GN; Karkanaki A; Karagiannis A; Mikhailidis DP; Athyros VG
Angiology; 2011 May; 62(4):285-90. PubMed ID: 21474465
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
19. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
Moran L; Teede H
Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
[TBL] [Abstract][Full Text] [Related]
20. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
